Teva Pharmaceutical Industries Ltd. won the latest round in a patent dispute involving its MS drug Copaxone. The U.S. Supreme Court reversed a lower court ruling that had invalidated a patent held by Teva Pharmaceuticals for its multiple sclerosis drug Copaxone.
Are you up for a challenge?
